Harnessing the Tide of Innovation: The Dual Faces of Generative AI in Applied Sciences; Letter to Editor
Applied Data Science and Analysis · 2024
DOI: 10.58496/adsa/2024/001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Data Science and Analysis, 2024. Verfasst von A.S. Albahri und 5 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Advancements in Artificial Intelligence (AI) and emerging generative capabilities added paradoxical aspects. One aspect is its positive impact and limitless power it brings to users. On the other hand, concerns about the misuse of this powerful tool have consistently increased [1]. AI advancements affect all domains and sectors as they evolve in their applicable nature in the applied sciences. The more powerful AI the more influence it has on the model workflow within the specific domain and its applied field [2]. This dual nature of generative AI ignited a wide discussion on implementation and produced a debate according to the latest employed tools and technologies by scientists and researchers.
Zitieren
APA
Albahri, A., Zahid, I. A., Yaseen, M. G., Aljanabi, M., Ali, A. H., & Kaleel, A. (2024). Harnessing the Tide of Innovation: The Dual Faces of Generative AI in Applied Sciences; Letter to Editor. Applied Data Science and Analysis. https://doi.org/10.58496/adsa/2024/001
Vancouver
Albahri A, Zahid IA, Yaseen MG, Aljanabi M, Ali AH, Kaleel A. Harnessing the Tide of Innovation: The Dual Faces of Generative AI in Applied Sciences; Letter to Editor. Applied Data Science and Analysis. 2024. doi:10.58496/adsa/2024/001
BibTeX
@article{Albahri2024,
author = {Albahri, A.S. and Zahid, Idrees A. and Yaseen, Mohanad G. and Aljanabi, Mohammad and Ali, Ahmed Hussein and Kaleel, Akhmed},
title = {Harnessing the Tide of Innovation: The Dual Faces of Generative AI in Applied Sciences; Letter to Editor},
journal = {Applied Data Science and Analysis},
year = {2024},
doi = {10.58496/adsa/2024/001}
}
EUVIMED